The CCI-779 Drug I've Been Getting Now Has a New Name -- Torisel

The link below tells about the FDA's approval of the drug as "Torisel" on May 30. It was approved for use against renal cell carcinoma. My mantle cell lymphoma is the second disease in which the manufacturer is seeking FDA approval. One bright avenue that the May 30 action opens for me is "off-label use." That means that its approval for one use allows doctors to prescribe it for other uses, since its safety in human beings is now established. So, I may be able to have it prescribed for my treatment extending beyond the end of my clinical trial on November 15. Some interesting technical description of the drug's novel mode of action.

http://www.curetoday.com/breaking_news/Archives/torisel05.30.07.htm

Dennis L. Gibson, Ph.D.